University of Crete (UOC)
Expression of programmed death-1 (PD-1) and PD-1 ligands in rheumatoid arthritis, in human and murine tissue, and their role in immunological tolerance
Abstract
dc:descriptionThe immune system has evolved to protect the body from foreign invading pathogens. To accomplish thiscritical role, T lymphocytes must discriminate between self and non-self. Among the mechanisms involved insafeguarding of self-tolerance, B7/CD28 membrane receptors are crucial for fine-tuning of T cell function.Programmed death-1 (PD-1) is an inhibitory lymphocyte receptor that has recently emerged as a key playerin induction and maintenance of tolerance.Rheumatoid arthritis (RA) is a chronic inflammatory disease of joints and extra-articular tissues, whichcauses severe disability and premature mortality [1, 2]. Numerous data support a central role of T cells inRA with these cells thought to be triggered locally in an antigen-specific manner resulting in breakdown oftolerance, synovial inflammation, and autoantibody production [3-7]. In the collagen-induced arthritis (CIAanimal model of RA, type II collagen (CII)– reactive CD4+ T cells are primary mediators of diseaseinduction driving autoantibody production by B cells and localized chronic inflammatory response [8-12].Although the role of co-stimulation is well documented in RA and has been further supported by the efficacyof CTLA4-Ig in severe RA, the role of this family of molecules has not been explored in a systematic,organized fashion. We sought to determine the role of PD-1/PD-1 ligands (PD-1L) in RA and test thehypothesis whether defective expression and/or function of this pathway may contribute to T cellhyperactivity within the inflamed joint.Genomic DNA was extracted from peripheral whole blood obtained from patients and healthy blood donors.Genotyping for the PD1.3A was performed by polymerase chain reaction (PCR). PD-1/PD-1L expression wasexamined on synovial tissue and synovial fluid (SF) mononuclear cells from RA patients byimmunohistochemistry and flow cytometry. PD-1 function was assessed in T cells stimulated with anti-CD3and PD-L1.Fc to crosslink PD-1. Collagen-induced arthritis (CIA) was induced in PD-1-/- C57Bl/6 mice andrecombinant PD-L1.Fc was injected to activate PD-1 in vivo.A. Human studiesTo determine whether PD-1 SNPs are associated with susceptibility to RA in our cohort, we analyzed thegenomic DNA of 86 RA patients and 227 age- and sex- matched healthy controls for the PD1.3 SNP. Nosubstantial difference in frequencies of PD1.3 heterozygosity (G/A) between RA patients and healthycontrols (15,1% versus 19,4%, p>0,05) was found.We have shown that RA synovium and SF were enriched in PD-1+ T cells (24 ± 5% vs. 2 ± 1% inosteoarthritis, p<0.01) and PD-1L+ monocytes/macrophages. And that PD-1 crosslinking inhibited T cell proliferation and IFN-γ production in RA patients. Howewver, despite high expression within the joint, PB Tcells incubated with RA SF and SF T cells from active RA exhibited reduced PD-1–mediated inhibition atsuboptimal –but not optimal– PD-L1.Fc concentrations, indicating a probable diminishing effect of theinflammatory microenvironment of RA on pathway’s function.B. Animal studiesPD-1-/- mice demonstrated increased incidence (73% vs. 36% in wild-type mice, p<0.05) and severity(mean maximum arthritis score 4.8 vs. 2.5, p=0.001) of CIA, associated with enhanced T cell proliferationand cytokine (IFN-γ, IL-17) production in response to type II collagen. Most interestingly, PD-L1.Fctreatment ameliorated CIA (mean maximum arthritis score 1.8 ± 0.6 vs. 2.5 ± 0.7) and reduced anticollagenII T cell responses (induction in proliferation [9cpm] 9594 ± 2147 vs. 4712 ± 2256).Taken together, our data suggest that τhe negative costimulatory PD-1/PD-1L pathway regulates peripheralT cell responses in both human and murine RA. The PD-1/PD-1L in rheumatoid synovium may represent anadditional target for immunomodulatory therapy in RA.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Raptopoulou, Amalia
- Ραπτοπούλου, Αμαλία
Subjects
dc:subject × 20- Ρευματοειδής αρθρίτιδα
- Μόριο προγραμματισμένου θανάτου - 1
- Συνδέτες 1 και 2 του μορίου προγραμματισμένου θανάτου - 1
- Ανοσολογική ανοχή
- Συνδιέγερση
- Αρθριτικό υγρό
- Αρθρίτιδα επαγόμενη με κολλαγόνο
- Τ κύτταρα
- Rheumatoid arthritis
- Programmed death-1 (PD-1)
- Programmed death-1 ligand 1/2 (PD-L 1/2)
- Immune tolerance
- Costimulation
- Synovial fluid
- Collagen induced arthritis
- T cells
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28945